Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nicox S.A (F: NXOA)

 
NXOA Technical Analysis
5
As on 23rd Dec 2024 NXOA STOCK Price closed @ 0.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.36 & Strong Sell for SHORT-TERM with Stoploss of 0.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NXOASTOCK Price

Open 0.25 Change Price %
High 0.26 1 Day 0.00 0.00
Low 0.24 1 Week 0.01 4.35
Close 0.24 1 Month 0.03 14.29
Volume 36 1 Year -0.20 -45.45
52 Week High 0.45 | 52 Week Low 0.10
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
NXOA
Daily Charts		 NXOA
Intraday Charts		 Whats New @
Bazaartrend		 NXOA
Free Analysis
 
NXOA Important Levels Intraday
RESISTANCE0.28
RESISTANCE0.27
RESISTANCE0.26
RESISTANCE0.25
SUPPORT0.23
SUPPORT0.22
SUPPORT0.21
SUPPORT0.20
 
NXOA Forecast December 2024
Share
4th UP Forecast0.37
3rd UP Forecast0.33
2nd UP Forecast0.3
1st UP Forecast0.28
1st DOWN Forecast0.2
2nd DOWN Forecast0.18
3rd DOWN Forecast0.15
4th DOWN Forecast0.11
 
NXOA Weekly Forecast
4th UP Forecast0.34
3rd UP Forecast0.31
2nd UP Forecast0.29
1st UP Forecast0.27
1st DOWN Forecast0.21
2nd DOWN Forecast0.19
3rd DOWN Forecast0.17
4th DOWN Forecast0.14
 
NXOA Forecast2024
4th UP Forecast0.95
3rd UP Forecast0.72
2nd UP Forecast0.58
1st UP Forecast0.44
1st DOWN Forecast0.04
2nd DOWN Forecast-0.1
3rd DOWN Forecast-0.24
4th DOWN Forecast-0.47
 
 
NXOA Other Details
Segment EQ
Market Capital 115676152.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NXOA Address
NXOA
 
NXOA Latest News
 
Your Comments and Response on Nicox S.A
 
NXOA Business Profile
Nicox S.A., an international ophthalmology company, develops innovative solutions to help maintain vision and improve ocular health. Its lead program in clinical development, NCX 470, a novel nitric oxide-donating prostaglandin analog, is in Phase 3 clinical trials for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, which is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis. It markets VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb; and ZERVIATE in allergic conjunctivitis licensed in various geographies, including to Eyevance Pharmaceuticals, LLC in the United States, and Ocumension Therapeutics in the Chinese and in the South East Asian markets. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France. Address: Drakkar 2 BAt D, Valbonne, France, 06560
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service